| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |